Skip navigation

Treatment of neurodegenerative conditions

Treatment of neurodegenerative conditions

BTG International Limited (2008) Treatment of neurodegenerative conditions. GB2442161/B.

Full text not available from this repository.


The use of a defined structure lipid glyceride comprising a glycerol moiety esterifed with one or more fatty acid moieties, characterised in that the lipid has a fatty acid moiety at the sn-2 position selected from the group consisting of q -linolenic acid and dihomo- q -linolenic acid for the manufacture of a medicament for the treatment of a neurodegenerative disease is provided characterised in that it is a lipid of formula II <PC>'''wherein <DL TSIZE=10> <DT>R<1> and R<3><DD>are the same and are selected from H, -C(O)(CH2)nCH3 wherein n is selected from 4 to 16, and <DT>R<2><DD>is selected from q -linolenoyl and dihomo- q -linolenoyl-residues. </DL> characterised in that the medicament is for daily dosing at between 1 and 20 grams of the lipid glyceride.

Item Type: Patent
Additional Information: Also published as GB2442161 (B)
Uncontrolled Keywords: triglycerides, neurodegenerative diseases, multiple sclerosis
Subjects: T Technology > T Technology (General) > T201 Patents. Trademarks
Faculty / School / Research Centre / Research Group: Faculty of Education, Health & Human Sciences > School of Human Sciences (HUM)
Related URLs:
Last Modified: 09 Oct 2021 04:46

Actions (login required)

View Item View Item